Active Ingredient(s): Poractant Alfa
FDA Approved: * November 18, 1999
Pharm Company: * DEY
Category: Neonatal (Infant)

Pulmonary surfactant is a surface-active complex of phospholipids and proteins formed by type II alveolar cells.[1] The proteins and lipids that make up the surfactant have both hydrophilic and hydrophobic regions. By adsorbing to the air-water interface of alveoli, with hydrophilic head groups in the water and the hydrophobic tails facing towards the air, the main lipid component of surfactant, dipalmitoylphosphatidylcholine (DPPC), reduces surface tension. As a medication, p... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Curosurf 80 mg/ml Endotracheal Suspension
NDC: 10122-510
Cornerstone Therapeutics Inc.
Curosurf 80 mg/ml Endotracheal Suspension
NDC: 63182-180
Chiesi Farmaceutici S.p.a.